BELLUS Health Inc (BLU) to Release Earnings on Tuesday
BELLUS Health Inc (BLU) opened at 0.365 on Monday. The company has a 50 day moving average of $0.40 and a 200 day moving average of $0.33. BELLUS Health Inc has a 1-year low of $0.21 and a 1-year high of $0.55. The firm’s market capitalization is $24.41 million.
In other news, Director Roberto Bellini acquired 225,000 shares of the stock in a transaction that occurred on Friday, July 14th. The shares were purchased at an average cost of C$0.35 per share, for a total transaction of C$78,750.00.
About BELLUS Health
BELLUS Health Inc is a drug development company focused on rare diseases. The business activities of the Company are development of the Company’s core technology platform, amyloid inhibitors, which focus on chemical compounds that could have the potential to inhibit the formation, deposition and toxicity of amyloid fibrils, which are the underlying causes of certain diseases.
Receive News & Stock Ratings for BELLUS Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BELLUS Health Inc and related stocks with our FREE daily email newsletter.